Ascend Advanced Therapies
Rockville, MD · Alachua, FL · Munich, DE
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
✓ EMA GMP (1)
○ MHRA GMP
Quick Facts: Ascend Advanced Therapies
- Signal Score
- 78.1/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100
- Headquarters
- Rockville, MD · Alachua, FL · Munich, DE
- Modalities
- AAV, Lentiviral, Plasmid
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Ascend Advanced Therapies
Spun out of former Spark Therapeutics manufacturing team.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
FDA InspectionsNo US records on file
EMA GMP Certificates1 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100
Sites: Philadelphia, PA
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals1 articles (not scored)
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100
Ascend Advanced Therapies EMA GMP Compliance 1 certificates
2024-09
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BY_04_GMP_2025_0088 | Ascend Advanced Therapies GmbH | Germany | 2024-09-19 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
ABL Ascend Advanced Therapies Names Suman Subramanian as Chief Business Officer - Via TT
ABL Ascend Advanced Therapies Names Suman Subramanian as Chief Business Officer Via TT
Frequently Asked Questions About Ascend Advanced Therapies
Does Ascend Advanced Therapies hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 EMA GMP certificate for Ascend Advanced Therapies.
What is Ascend Advanced Therapies's CDMO Signal Score?
Ascend Advanced Therapies has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Ascend Advanced Therapies for a manufacturing program?
Use the free AI matchmaker to compare Ascend Advanced Therapies against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 77.6
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish
Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Compare Ascend Advanced Therapies with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.